Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer
about
Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy.Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate.Mass spectrometry theory and application to adrenal diseases.Defining a new testosterone threshold for medical castration: Results from a prospective cohort series.Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasiaTestosterone replacement therapy and voiding dysfunction.Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy.Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer.Testosterone Replacement Therapy on the Natural History of Prostate Disease.Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer.The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).Testosterone Rescues the De-Differentiation of Smooth Muscle Cells Through Serum Response Factor/Myocardin.Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders
P2860
Q34294888-2D508D0A-D42F-4993-A5AE-DB1A0A7052FEQ36360868-403E49EF-A53D-4E89-827A-108A15D4BA24Q36763071-1F454295-863B-4CC2-B37A-2EF1341C8110Q36889401-700490D8-AAA4-40E2-9020-C57736DADA0FQ37161245-C0527CF2-D566-4D07-A6D4-B184EC11A249Q37531050-14B03F6D-5C6E-4ABE-8007-9E37F7038149Q37531098-0ADA0AB4-6908-4BC9-BDFA-A616011A69CAQ37613206-D31F7182-1E03-4BB0-8F55-5577679C7600Q38528388-67CDC8BE-6602-4EBF-A60F-D4D25141AA41Q38736795-74A723C9-E517-4C55-BF0B-4883758DE45DQ39256655-AB07EE8B-96CA-4DA2-9137-46B9A74FB390Q46720614-49DE3F66-6284-47D4-B842-9E8305D22ADFQ48348756-17250860-79EE-4B41-981D-B34FACC42647Q51318990-D5C53657-F506-4313-8AA0-19D8321AE36FQ58802199-39113586-5D39-47AC-8F9D-AD56E9ED1818
P2860
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Intraprostatic testosterone an ...... yperplasia and prostate cancer
@ast
Intraprostatic testosterone an ...... yperplasia and prostate cancer
@en
Intraprostatic testosterone an ...... yperplasia and prostate cancer
@nl
type
label
Intraprostatic testosterone an ...... yperplasia and prostate cancer
@ast
Intraprostatic testosterone an ...... yperplasia and prostate cancer
@en
Intraprostatic testosterone an ...... yperplasia and prostate cancer
@nl
prefLabel
Intraprostatic testosterone an ...... yperplasia and prostate cancer
@ast
Intraprostatic testosterone an ...... yperplasia and prostate cancer
@en
Intraprostatic testosterone an ...... yperplasia and prostate cancer
@nl
P2093
P2860
P1433
P1476
Intraprostatic testosterone an ...... yperplasia and prostate cancer
@en
P2093
André N Vis
Eric J H Meuleman
Hong N Bui
R Jeroen A van Moorselaar
Tim M van der Sluis
P2860
P304
P356
10.1111/J.1464-410X.2011.10651.X
P407
P577
2011-10-12T00:00:00Z